{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:34:58Z","timestamp":1793176498533,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Global Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.xphs.2026.104533","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:26:06Z","timestamp":1791386766000},"page":"104533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond specification equivalence: A CMA\u2013CQA framework for raw material change and lifecycle variability assessment"],"prefix":"10.1016","volume":"115","author":[{"given":"Alberto","family":"Berardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Durkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schwenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitriona","family":"Cashell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xphs.2026.104533_bib0001","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.xphs.2023.10.014","article-title":"A rational hierarchy to capture raw material attribute variability in the pharmaceutical drug product development and manufacturing lifecycle","volume":"113","author":"Conway","year":"2024","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104533_bib0002","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","article-title":"ICH guideline Q8 (R2) on pharmaceutical development","year":"2009"},{"key":"10.1016\/j.xphs.2026.104533_bib0003","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","article-title":"ICH guideline Q9 (R1) on quality risk management","year":"2023"},{"key":"10.1016\/j.xphs.2026.104533_bib0004","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use","article-title":"ICH guideline Q10 on pharmaceutical quality system","year":"2008"},{"issue":"4","key":"10.1016\/j.xphs.2026.104533_bib0005","article-title":"Quality risk management of compliant excipients","volume":"3","author":"Carlin","year":"2012","journal-title":"J Excipients Food Chem (Int J Pharmaceut Excipients)"},{"key":"10.1016\/j.xphs.2026.104533_bib0006","series-title":"Excipient Quality: Beyond the Pharmacopeia Monograph | Tablets & Capsules Magazine","article-title":"Excipient quality: beyond the pharmacopeia monograph. Tablets & capsules","author":"Moreton","year":"2020"},{"issue":"3","key":"10.1016\/j.xphs.2026.104533_bib0007","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/jps.24299","article-title":"Excipient variability and its impact on dosage form functionality","volume":"104","author":"Dave","year":"2015","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104533_bib0008","doi-asserted-by":"crossref","unstructured":"Convention USP. General chapter \u27e81059\u27e9 excipient performance. United States Pharmacopeia \u2013 National Formulary (USP\u2011NF). 2024. https:\/\/doi.org\/10.31003\/USPNF_M2312_07_01.","DOI":"10.31003\/USPNF_M2312_07_01"},{"issue":"2","key":"10.1016\/j.xphs.2026.104533_bib0009","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/10837450.2011.604784","article-title":"Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development","volume":"18","author":"Kushner","year":"2013","journal-title":"Pharm Dev Technol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104533_bib0010","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/jps.22455","article-title":"Examining the impact of excipient material property variation on drug product quality attributes: a quality-by-design study for a roller compacted, immediate release tablet","volume":"100","author":"Kushner","year":"2011","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104533_bib0011","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1016\/j.xphs.2024.08.003","article-title":"Past, current and future: application of image analysis in small molecule pharmaceutical development","volume":"113","author":"Gamble","year":"2024","journal-title":"J Pharm Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104533_bib0012","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1080\/10837450.2018.1534862","article-title":"Multivariate analysis as a method to understand variability in a complex excipient, and its contribution to formulation performance","volume":"23","author":"Tobyn","year":"2018","journal-title":"Pharm Dev Technol"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104533_bib0013","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijpharm.2018.08.014","article-title":"A multivariate raw material property database to facilitate drug product development and enable in-silico design of pharmaceutical dry powder processes","volume":"549","author":"Van Snick","year":"2018","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.xphs.2026.104533_bib0014","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1208\/s12249-022-02434-2","article-title":"Particle property characterization and data curation for effective powder property modeling in the pharmaceutical industry","volume":"23","author":"Wadams","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"12","key":"10.1016\/j.xphs.2026.104533_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.104021","article-title":"Understanding the impact of excipient variability on oral solid dosage form performance: a possible role for multivariate data analysis, in the form of principal component analysis","volume":"114","author":"Janssen","year":"2025","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104533_bib0016","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ces.2016.10.031","article-title":"Modelling of artefacts in estimations of particle size of needle-like particles from laser diffraction measurements","volume":"158","author":"Agimelen","year":"2017","journal-title":"Chem Eng Sci"},{"key":"10.1016\/j.xphs.2026.104533_bib0017","series-title":"Particle Size Measurements: Fundamentals, Practice, Quality","first-page":"13","article-title":"Particle size, size distributions and shape","author":"Merkus","year":"2009"},{"issue":"2","key":"10.1016\/j.xphs.2026.104533_bib0018","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.powtec.2007.11.017","article-title":"Particle shape and orientation in laser diffraction and static image analysis size distribution analysis of micrometer sized rectangular particles","volume":"186","author":"Tinke","year":"2008","journal-title":"Powder Technol"},{"issue":"11","key":"10.1016\/j.xphs.2026.104533_bib0019","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.3390\/app14114802","article-title":"Particle sizing and surface area measurements: a comparative assessment of commercial air permeability and laser light diffraction instruments","volume":"14","author":"Konstanty","year":"2024","journal-title":"Appl Sci"},{"issue":"10","key":"10.1016\/j.xphs.2026.104533_bib0020","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1007\/s11095-012-0842-1","article-title":"Effect of milling on particle shape and surface energy heterogeneity of needle-shaped crystals","volume":"29","author":"Ho","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2026.104533_bib0021","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2022.10.012","article-title":"The impact of lactose type on disintegration: an integral study on porosity and polymorphism","volume":"180","author":"Janssen","year":"2022","journal-title":"Euro J Pharmaceut Biopharmaceut"},{"issue":"1","key":"10.1016\/j.xphs.2026.104533_bib0022","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jps.10513","article-title":"Visualization of the crystallization of lactose from the amorphous state","volume":"93","author":"Price","year":"2004","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2026.104533_bib0023","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-5173(94)90458-8","article-title":"The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders","volume":"105","author":"Briggner","year":"1994","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2026.104533_bib0024","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2014.06.055","article-title":"Microcrystalline cellulose, a direct compression binder in a quality by design environment\u2014A review","volume":"473","author":"Thoorens","year":"2014","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1016\/j.xphs.2026.104533_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2015.05.026","article-title":"Understanding the impact of microcrystalline cellulose physicochemical properties on tabletability","volume":"490","author":"Thoorens","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2026.104533_bib0026","series-title":"Pharmaceutical Excipients","article-title":"Magnesium stearate","year":"2021"},{"issue":"1","key":"10.1016\/j.xphs.2026.104533_bib0027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/lubricants2010021","article-title":"Lubricants in pharmaceutical solid dosage forms","volume":"2","author":"Li","year":"2014","journal-title":"Lubricants"},{"key":"10.1016\/j.xphs.2026.104533_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2025.114803","article-title":"Quantifying cross-linking strength in sodium starch glycolate and its impact on tablet disintegration and dissolution","volume":"214","author":"Janssen","year":"2025","journal-title":"Euro J Pharmaceut Biopharmaceut"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:51:56Z","timestamp":1793173916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0022354926003837"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104533","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond specification equivalence: A CMA\u2013CQA framework for raw material change and lifecycle variability assessment","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104533","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104533"}}